2.17
+0(+0.00%)
Currency In USD
| Previous Close | 2.17 |
| Open | 2.18 |
| Day High | 2.19 |
| Day Low | 2.15 |
| 52-Week High | 2.63 |
| 52-Week Low | 1.59 |
| Volume | 61,643 |
| Average Volume | 270,346 |
| Market Cap | 127.7M |
| PE | -1.54 |
| EPS | -1.41 |
| Moving Average 50 Days | 2.06 |
| Moving Average 200 Days | 2.11 |
| Change | 0 |
If you invested $1000 in Seer, Inc. (SEER) since IPO date, it would be worth $38.43 as of July 10, 2025 at a share price of $2.17. Whereas If you bought $1000 worth of Seer, Inc. (SEER) shares 3 years ago, it would be worth $212.54 as of July 10, 2025 at a share price of $2.17.
For more details, use our stock calculator to calculate how much you would've made investing different amounts on specific dates.
Seer’s Proteograph Platform Enables Unprecedented 20,000-Sample Proteomics Study with Korea University to Develop AI-Driven Diagnostics for Cancers in Young Adults
GlobeNewswire Inc.
Jun 01, 2025 11:00 AM GMT
First-of-its-kind study will use Seer’s next-generation workflow to identify early-onset cancer biomarkers and power deep, unbiased mass spectrometry-based proteomics Seer’s new Proteograph ONE Assay to accelerate analysis and reduce costs, making la
Seer Redefining Deep Unbiased Proteomics with Launch of New Proteograph Workflow at ASMS 2025, Enabling Previously Unattainable Scale and Efficiency
GlobeNewswire Inc.
May 29, 2025 11:00 AM GMT
REDWOOD CITY, Calif., May 29, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced the launch of its new Proteograph® Product Suite, featuring the Proteograph ONE
Seer to Report First Quarter 2025 Financial Results on May 13, 2025
GlobeNewswire Inc.
Apr 24, 2025 8:05 PM GMT
REDWOOD CITY, Calif., April 24, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), a leading life sciences company commercializing a disruptive new platform for proteomics, today announced that it will report financial results for the first quarte